{"transactions":[{"id":1809171,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-14T20:23:27.000Z","date":"2023-08-11","kind":"sale","planned":false,"acquired":false,"shares":59052,"price":14.015,"value":827613.78,"ownership":{"direct":false,"nature":"By SkyKnight Capital Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by SkyKnight Capital Fund II, L.P. (\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":5565126,"source":{"system":"sec-edgar","filing":"0000950170-23-042448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000095017023042448/ownership.xml","form_type":"4"}},{"id":1809170,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-14T20:23:27.000Z","date":"2023-08-11","kind":"sale","planned":false,"acquired":false,"shares":137787,"price":14.015,"value":1931084.805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\"). SkyKnight Capital, L.P. (\"SkyKnight Capital\") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC (\"SkyKnight Capital Management\") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2815117,"source":{"system":"sec-edgar","filing":"0000950170-23-042448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000095017023042448/ownership.xml","form_type":"4"}},{"id":1809169,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-14T20:23:27.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":38636,"price":14.0462,"value":542688.9832,"ownership":{"direct":false,"nature":"By SkyKnight Capital Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by SkyKnight Capital Fund II, L.P. (\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":5624178,"source":{"system":"sec-edgar","filing":"0000950170-23-042448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000095017023042448/ownership.xml","form_type":"4"}},{"id":1809168,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-14T20:23:27.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":90152,"price":14.0462,"value":1266293.0224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\"). SkyKnight Capital, L.P. (\"SkyKnight Capital\") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC (\"SkyKnight Capital Management\") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2952904,"source":{"system":"sec-edgar","filing":"0000950170-23-042448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000095017023042448/ownership.xml","form_type":"4"}},{"id":2232004,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T20:15:23.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":100000,"price":17.2201,"value":1722010.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.0548 to $17.4650. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. (\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":3043056,"source":{"system":"sec-edgar","filing":"0000899243-22-022559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322022559/doc4.xml","form_type":"4"}},{"id":2234905,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:35:48.000Z","date":"2022-06-10","kind":"purchase","acquired":true,"shares":7923,"price":17.3906,"value":137785.7238,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.06 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. (\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2943056,"source":{"system":"sec-edgar","filing":"0000899243-22-022193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322022193/doc4.xml","form_type":"4"}},{"id":2234904,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:35:48.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":5999,"price":17.498,"value":104970.502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.47 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. (\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2935133,"source":{"system":"sec-edgar","filing":"0000899243-22-022193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322022193/doc4.xml","form_type":"4"}},{"id":2246130,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T21:40:00.000Z","date":"2022-06-01","kind":"purchase","acquired":true,"shares":35091,"price":17.5686,"value":616499.7426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.45 to $17.65. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2929134,"source":{"system":"sec-edgar","filing":"0000899243-22-021040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322021040/doc4.xml","form_type":"4"}},{"id":2254501,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:15:54.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":200,"price":17.5,"value":3500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2894043,"source":{"system":"sec-edgar","filing":"0000899243-22-019927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322019927/doc4.xml","form_type":"4"}},{"id":2258959,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-24T20:43:31.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":100000,"price":17.2723,"value":1727230.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.00 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2893843,"source":{"system":"sec-edgar","filing":"0000899243-22-019372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322019372/doc4.xml","form_type":"4"}},{"id":2258958,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-24T20:43:31.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":9300,"price":17.4363,"value":162157.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.21 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2793843,"source":{"system":"sec-edgar","filing":"0000899243-22-019372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322019372/doc4.xml","form_type":"4"}},{"id":2258957,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-24T20:43:31.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":100000,"price":17.3294,"value":1732940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2784543,"source":{"system":"sec-edgar","filing":"0000899243-22-019372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322019372/doc4.xml","form_type":"4"}},{"id":2266696,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:16:31.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":21632,"price":16.2028,"value":350498.9696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.94 to $16.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2684543,"source":{"system":"sec-edgar","filing":"0000899243-22-018602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322018602/doc4.xml","form_type":"4"}},{"id":2271174,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T20:15:18.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":100000,"price":15.9396,"value":1593960.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.64 to $16.39. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2662911,"source":{"system":"sec-edgar","filing":"0000899243-22-018138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322018138/doc4.xml","form_type":"4"}},{"id":2271173,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T20:15:18.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":55502,"price":15.3342,"value":851078.7684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.16 to $15.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2562911,"source":{"system":"sec-edgar","filing":"0000899243-22-018138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322018138/doc4.xml","form_type":"4"}},{"id":2271172,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T20:15:18.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":24652,"price":14.7688,"value":364080.4576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.16 to $15.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2507409,"source":{"system":"sec-edgar","filing":"0000899243-22-018138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322018138/doc4.xml","form_type":"4"}},{"id":2334374,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-15T21:01:45.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":25000,"price":15.2467,"value":381167.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.21 to $15.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2482757,"source":{"system":"sec-edgar","filing":"0000899243-22-011073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322011073/doc4.xml","form_type":"4"}},{"id":2334373,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-15T21:01:45.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":17486,"price":15.5,"value":271033.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2457757,"source":{"system":"sec-edgar","filing":"0000899243-22-011073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322011073/doc4.xml","form_type":"4"}},{"id":2345836,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":1,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":2,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":3,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-08T23:05:11.000Z","date":"2022-03-04","kind":"purchase","acquired":true,"shares":13352,"price":14.9989,"value":200265.3128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.98 to $15.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\"). SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2440271,"source":{"system":"sec-edgar","filing":"0000899243-22-009977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322009977/doc4.xml","form_type":"4"}},{"id":2345835,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2022-03-08T23:00:17.000Z","date":"2021-03-19","kind":"exercise","acquired":false,"shares":11710.45,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By SkyKnight Capital Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1171045},"source":{"system":"sec-edgar","filing":"0000899243-22-009973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322009973/doc4.xml","form_type":"4"}},{"id":2345834,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2022-03-08T23:00:17.000Z","date":"2021-03-19","kind":"exercise","acquired":false,"shares":27324.4,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. (\"SkyKnight Capital\") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC (\"SkyKnight Capital Management\") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2732440},"source":{"system":"sec-edgar","filing":"0000899243-22-009973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322009973/doc4.xml","form_type":"4"}},{"id":2345833,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-08T23:00:17.000Z","date":"2021-03-19","kind":"exercise","acquired":true,"shares":1171045,"ownership":{"direct":false,"nature":"By SkyKnight Capital Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC (\"SkyKnight II GP\") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2426919,"source":{"system":"sec-edgar","filing":"0000899243-22-009973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322009973/doc4.xml","form_type":"4"}},{"id":2345832,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":110608,"kind":"person","name":"SkyKnight Aero Holdings, LLC","position":1,"cik":"0001793034","reported_name":"SkyKnight Aero Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98350,"kind":"organization","name":"SkyKnight Capital, L.P.","position":2,"cik":"0001842707","reported_name":"SkyKnight Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110609,"kind":"person","name":"SkyKnight Capital Management, LLC","position":3,"cik":"0001842708","reported_name":"SkyKnight Capital Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110610,"kind":"person","name":"SkyKnight Capital Fund II, L.P.","position":4,"cik":"0001748212","reported_name":"SkyKnight Capital Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":110611,"kind":"person","name":"SkyKnight Capital II GP, LLC","position":5,"cik":"0001842706","reported_name":"SkyKnight Capital II GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":98351,"kind":"person","name":"Ebbel Matthew","position":6,"cik":"0001842704","reported_name":"Ebbel Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-08T23:00:17.000Z","date":"2021-03-19","kind":"exercise","acquired":true,"shares":2732440,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC (\"SkyKnight Aero Holdings\") and SkyKnight Capital Fund II, L.P. \"(\"SkyKnight Fund II\") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. (\"SkyKnight Capital\") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC (\"SkyKnight Capital Management\") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":5662814,"source":{"system":"sec-edgar","filing":"0000899243-22-009973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842704/000089924322009973/doc4.xml","form_type":"4"}}]}